Characterizing weekly self-reported antihypertensive medication nonadherence across repeated occasions

Patient Preference and Adherence

Volumn 8, Issue , 2014, Pages 643-650

  Voils, Corrine I ^a,b   King, Heather A ^a   Neelon, Brian ^a,b   Hoyle, Rick H ^a   Reeve, Bryce B ^c   Maciejewski, Matthew L ^a,b   Yancy Jr , William S ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

Author keywords

Adherence; Compliance; Hypertension; Intraindividual variability

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; CLINICAL DECISION MAKING; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; ETHNICITY; FEMALE; HEALTH CARE; HEALTH CARE COST; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT CARE; PATIENT COMPLIANCE; PROSPECTIVE STUDY; SELF CONCEPT; SELF REPORT; SINGLE DRUG DOSE;

EID: 84900393875     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S60715     Document Type: Article

References (34)

1. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;(2):CD000011.
2. Ogedegbe GO, Boutin-Foster C, et al. A randomized controlled trial of positive-affect intervention and medication adherence in hypertensive African Americans. Arch Intern Med. 2012;172(4):322-326.
3. Ogedegbe G, Chaplin W, Schoenthaler A, et al. A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens. 2008;21(10):1137-1143.
4. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med. 2004;164(7): 722-732.
5. Knafl GJ, Bova CA, Fennie KP, O'Malley JP, Dieckhaus KD, Williams AB. An analysis of electronically monitored adherence to antiretroviral medications. AIDS Behav. 2010;14(4):755-768.
6. Nesselroade JR. The warp and woof of the developmental fabric. In: Downs R, Liben L, Palermo D, editors. Visions of Development, the Environment, and Aesthetics: The Legacy of Joachim F. Wohlwil. Hillsdale, NJ: Lawrence Erlbaum Associates; 1991:213-240.
7. McDonald-Miszczak L, Neupert SD, Gutman G. Does cognitive ability explain inaccuracy in older adults' self-reported medication adherence? J Appl Gerontol. 2009;28(5):560-581.
8. Zedler BK, Joyce A, Murrelle L, Kakad P, Harpe SE. A pharmacoepidemiologic analysis of the impact of calendar packaging on adherence to self-administered medications for long-term use. Clin Ther. 2011;33(5):581-597.
9. Schneider PJ, Murphy JE, Pedersen CA. Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients. J Am Pharm Assoc (2003). 2008;48(1):58-63.
10. Christensen A, Christrup LL, Fabricius PE, et al. The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy: a randomized controlled trial. J Hypertens. 2010;28(1):194-200.
11. Chernew ME, Shah MR, Wegh A, et al. Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff (Millwood). 2008;27(1):103-112.
12. Friedman RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9(4 Pt 1):285-292.
13. Márquez-Contreras E, Martell-Claros N, Gil-Guillén V, et al; Compliance Group of the Spanish Society of Hypertension (SEE). Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study. J Hypertens. 2006;24(1):169-175.
14. Girvin B, McDermott BJ, Johnston GD. A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance. J Hypertens. 1999;17(11):1627-1631.
15. Márquez Contreras E, Vegazo García O, Martel Claros N, et al. Efficacy of telephone and mail intervention in patient compliance with antihypertensive drugs in hypertension. ETECUM-HTA study. Blood Press. 2005;14(3):151-158.
16. Voils CI, Maciejewski ML, Hoyle RH, et al. Initial validation of a self-report measure of the extent of and reasons for medication nonadherence. Med Care. 2012;50(12):1013-1019.
17. Callahan CM, Unverzagt FW, Hui SL, Perkins AJ, Hendrie HC. Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care. 2002;40(9):771-781.
18. Paulhus D. Paulhus Deception Scales. Pearson Assessment, London; 1998.
19. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1-24.
20. Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epidemiol. 2003;56(6): 520-529.
21. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-354.
22. Tourangeau R, Rips LJ, Rasinski K. The Psychology of Survey Response. New York: Cambridge University Press; 2000.
23. Voils CI, Hoyle RH, Thorpe CT, Maciejewski ML, Yancy WS Jr. Improving the measurement of self-reported medication nonadherence. J Clin Epidemiol. 2011;64(3):250-254.
24. Ram N, Gerstorf D. Time-structured and net intraindividual variability: tools for examining the development of dynamic characteristics and processes. Psychol Aging. 2009;24(4):778-791.
25. Snijders T, Bosker RJ. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. Thousand Oaks, CA: Sage Publications; 1999.
26. Hedeker D, Gibbons R. Longitudinal Data Analysis. Hoboken, NJ: John Wiley & Sons; 2006.
27. Hox J. Multilevel Analysis: Techniques and Applications. Mahwah, NJ: Lawrence Erlbaum Associated; 2002.
28. Hedeker D. Generalized linear mixed models. In: Everitt B, Howell H, editors. Encyclopedia of Statistics in Behavioral Science. New York: Wiley; 2005.
29. Almeida DM, Piazza JR, Stawski RS. Interindividual differences and intraindividual variability in the cortisol awakening response: an examination of age and gender. Psychol Aging. 2009;24(4):819-827.
30. Wagner GJ, Ghosh-Dastidar B. Electronic monitoring: adherence assessment or intervention? HIV Clin Trials. 2002;3(1):45-51.
31. van Onzenoort HA, Menger FE, Neef C, et al. Participation in a clinical trial enhances adherence and persistence to treatment: a retrospective cohort study. Hypertension. 2011;58(4):573-578.
32. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43 Suppl 1:S79-S87.
33. Powers BJ, Olsen MK, Smith VA, Woolson RF, Bosworth HB, Oddone EZ. Measuring blood pressure for decision making and quality reporting: where and how many measures? Ann Intern Med. 2011;154(12):781-788.
34. Estabrooks PA, Boyle M, Emmons KM, et al. Harmonized patient-reported data elements in the electronic health record: supporting meaningful use by primary care action on health behaviors and key psychosocial factors. J Am Med Inform Assoc. 2012;19(4):575-582.